IFNB1 and neoplasm: As type I IFNs (IFNβ) bind to all nucleated cells and type III (IFNλ) bind to epithelial cells, this fusion allows for the binding and delivery of the drug to different cell subsets, including tumor and immune cells within the tumor microenvironment [221, 222].